The effects of narcotic-antagonist analgesics on rat brain cholinesterases. 1969

W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst

UI MeSH Term Description Entries
D008297 Male Males
D009019 Morphinans Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS. Morphinan
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009269 Nalorphine A narcotic antagonist with some agonist properties. It is an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. Given alone it produces a broad spectrum of unpleasant effects and it is considered to be clinically obsolete. Allylnormorphine,Lethidrone,Nalorphine Hydrobromide,Nalorphine Hydrochloride,Nalorphine, (14 alpha)-Isomer,Nalorphine, L-tartrate (1:1),Hydrobromide, Nalorphine,Hydrochloride, Nalorphine
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002087 Butyrates Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure. Butyrate,n-Butyrate,Butanoic Acids,Butyric Acids,Acids, Butanoic,Acids, Butyric,n Butyrate
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D003496 Cyclazocine An analgesic with mixed narcotic agonist-antagonist properties.
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic

Related Publications

W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
February 1973, Toxicology and applied pharmacology,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
January 1967, Annual review of pharmacology,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
December 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
August 1976, Life sciences,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
June 1973, Journal of pharmaceutical sciences,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
July 1968, The Journal of pharmacy and pharmacology,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
July 1970, British journal of pharmacology,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
September 1974, Research communications in chemical pathology and pharmacology,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
August 1980, Life sciences,
W L Dewey, and L S Harris, and J F Howes, and J S Kennedy, and J A Nuite, and V Hayhurst
August 1976, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!